Ruhi Gulati

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Epithelial Mesenchymal Transition

Induced Apoptosis

Histone Deacetylase

Small Cell Lung Cancer

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Ruhi Gulati, Yasmeen Fleifil, Katherine Jennings, Alexander J Bondoc, Greg Tiao, James Geller, Lubov Timchenko, Nikolai Timchenko
Inhibition of Histone Deacetylase Activity Increases Cisplatin Efficacy to Eliminate Metastatic Cells in Pediatric Liver Cancers. Cancers 16 (13) (2024)
Ruhi Gulati, Yasmeen Fleifil, Katherine Jennings, Alexander J Bondoc, Greg Tiao, James Geller, Lubov Timchenko, Nikolai Timchenko
Inhibition of Histone Deacetylase Activity Increases Cisplatin Efficacy to Eliminate Metastatic Cells in Pediatric Liver Cancers. Cancers 16 (13) (2024)
Ruhi Gulati, Margaret A Hanlon, Maggie Lutz, Tyler Quitmeyer, James Geller, Gregory Tiao, Lubov Timchenko, Nikolai Timchenko
Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma. Cancers 14 (24) (2022)
Ruhi Gulati, Margaret A Hanlon, Maggie Lutz, Tyler Quitmeyer, James Geller, Gregory Tiao, Lubov Timchenko, Nikolai Timchenko
Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma. Cancers 14 (24) (2022)
Ruhi Gulati, Margaret A Hanlon, Maggie Lutz, Tyler Quitmeyer, James Geller, Gregory Tiao, Lubov Timchenko, Nikolai Timchenko
Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma. Cancers 14 (24) (2022)